Asia-Pacific ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Solution ; Modality ; End User

Asia-Pacific ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Solution ; Modality ; End User

  • June 2021 •
  • 148 pages •
  • Report ID: 6103130 •
  • Format: PDF
The ePRO, ePatient diaries, and eCOA market in Asia Pacific is expected to grow from US$ 348.8 million in 2021 to US$ 964.2 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. Healthcare systems are experiencing a rise in consumer engagement worldwide. In developing countries, health care systems are becoming more technologically friendly, and experiencing an internationalization of the market. Moreover, with increasing investments in Asia Pacific healthcare sector, IT start-ups offer lucrative opportunities for the market’s growth. For instance, in December 2020, DXY, a Chinese healthcare portal company, raised US$ 500 million in a Series E round led by Trustbridge Partners. Indonesian healthtech platform—Alodokter—raised US$ 33 million Series C funding. Growing healthcare IT industry in Asia Pacific is anticipated to provide lucrative opportunities for players to expand their capabilities in the region. Also, COVID-19 has accelerated the use of digital health technologies globally. The pandemic has prioritized remote monitoring solutions. Governments in the region are promoting telemedicine, offering lucrative opportunities for the ePRO, e-Patient Diaries, and eCOA market in coming years. In March 2020, the Indian government issued the Telemedicine Practice Guidelines to enable registered medical practitioners to provide healthcare services using telecommunication and digital technologies.
The market for ePRO, ePatient diaries, and eCOA market is segmented into type of solution, modality, and end user.In 2020, the eCOA (Electronic Clinical Outcome Assessments) segment accounted for the largest share of the Asia Pacific ePRO, ePatient diaries, and eCOA market.

This large share can be attributed to the advantages offered by eCOA, as eCOA uses technology such as smartphones, laptops, computers to enable patients, nurses, and doctors to consult directly about medical test results. eCOA provides highly accurate knowledge that better understands and simplifies the acceptance process for patient reviews in clinical trials. In addition, the increasing cost for pharmaceutical manufacturers of modern overall drug development methodologies has led to their use of electronic information collection by way of paper-based processes. Data processing across eCOA networks improves the quality of the information gathered, harmonizes data systems, and gives users valuable benefits, such as data interpretation.
The DIA China Digital Health Community organized a series of Remote Digital Clinical Trials During COVID-19 Pandemic online seminars to increase global interest in remote clinical trials and digital clinical trial resources.Veteran clinicians and researchers presented real-life examples of remote clinical trial and digital trial technology implementations in China and strategies and plans based on their experiences.

Sponsors and CROs have been able to preserve their business continuity in China by using remote clinical trials to overcome the difficulties of conducting conventional clinical trials faced by the COVID-19 pandemic (impacting on-site subject visits, data monitoring, and drug delivery).However, since these trials are just getting underway in China, it is important to optimize the effect of these technologies and services, and relevant regulations should evolve to support these developments accordingly.

Thus, ePRO, e-Patient Diaries, and eCOA market is moderately impacted due to COVID-19 pandemic.
The overall Asia Pacific ePRO, ePatient Diaries, and eCOA market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.

The process also serves the purpose of obtaining overview and forecast for the Asia Pacific ePRO, ePatient Diaries, and eCOA market with respects to all the segments pertaining to the region.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic.

The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the Asia Pacific ePRO, ePatient Diaries, and eCOA market.ERT Clinical; ArisGlobal LLC; The Diary Pte.

Ltd; ICON PLC; PAREXEL INTERNATIONAL CORPORATION; Anju Software, Inc.; Kayentis; Bracket Global LLC; Dassault Systèmes SE; and CRF Health are among a few players operating in the Asia Pacific ePRO, ePatient Diaries, and eCOA market.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.